GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like Boston's InSpire MD Eyes $24.8 Million Series C Round January 25, 2017 UK's Makes Debut at October 9, 2017 Medtronic EVP & RTG President To Speak At Cowen and Company Healthcare Conference February 26, 2017
